#USA #New York #Class Action #Gross Law Firm #PepGen Inc

The Gross Law Firm Issues Notice to PepGen Inc. Shareholders

In a critical update for investors, The Gross Law Firm has officially notified shareholders of PepGen Inc. (NASDAQ: PEPG) regarding a class action lawsuit. This action comes in light of serious allegations that could impact both the company and its investors significantly. As the deadline for participation approaches, shareholders need to be informed about their rights and the implications of this legal action.

Timeline and Important Details

The class action period for which claims can be registered spans from March 7, 2024, to March 3, 2025. Investors who purchased shares during this timeframe are encouraged to contact The Gross Law Firm to discuss their potential for lead plaintiff appointment. Notably, being appointed as a lead plaintiff is not a prerequisite for participating in the recovery process.

The specific allegations outlined in the lawsuit suggest that PepGen Inc. misled its investors about the efficacy and safety of its lead product candidate, PGN-EDO51. The complaint states that the company potentially misrepresented the data regarding this candidate and the associated study, known as the CONNECT2 study. It is claimed that this study might not meet the necessary standards required for approval by the U.S. Food and Drug Administration (FDA).

Allegations in Detail:

• - Misleading Statements: The company allegedly made materially false and misleading claims regarding the effectiveness of PGN-EDO51, potentially inflating its market value and misleading investors.
• - Dangerous Studies: Concerns were raised that the CONNECT2 study was not only deficient but may have also posed risks that were not disclosed to investors.
• - Overstated Prospects: The lawsuit suggests that the commercial and regulatory prospects for PGN-EDO51 were grossly overstated, leading to a misleading view of the company’s future.

Upcoming Deadline

Investors must take immediate action to register for the class action if they hold shares of PepGen within the designated period. The final date for submitting lead plaintiff applications is August 8, 2025. Shareholders are strongly advised not to delay in registering their information. Doing so will ensure they are monitored throughout the lifecycle of the case through portfolio monitoring software provided by The Gross Law Firm.

Why Choose The Gross Law Firm?

Recognized nationally, The Gross Law Firm is dedicated to protecting investors from deceitful practices in the market. Their focus is on holding corporations accountable for misleading actions that lead to financial harm for shareholders. The firm advocates for responsible corporate conduct and seeks to redress the losses incurred by investors hit by fraudulent statements and omissions related to stock valuations.

Contact Information:
For investors interested in more information or who wish to register for the class action, please reach out via:

• - Website: Gross Law Firm Contact
• - Phone: (646) 453-8903
• - Address: 15 West 38th Street, 12th Floor, New York, NY, 10018

Conclusion

With a backup from The Gross Law Firm, PepGen Inc. shareholders have the chance to pursue legal action following potentially misleading business practices. This serves as an essential reminder of the rights and means available to investors during complex legal climates, especially when facing class action lawsuits. The deadline is fast approaching, and the time to act is now.